Bulevirtide Monotherapy Is Safe and Well Tolerated in Chronic Hepatitis Delta: An Integrated Safety Analysis of Bulevirtide Clinical Trials at Week 48.
Saved in:
| Title: | Bulevirtide Monotherapy Is Safe and Well Tolerated in Chronic Hepatitis Delta: An Integrated Safety Analysis of Bulevirtide Clinical Trials at Week 48. |
|---|---|
| Authors: | Asselah T; Department of Hepatology, Hôpital Beaujon, Université de Paris-Cité, INSERM UMR1149, Clichy, France., Lampertico P; Division of Gastroenterology and Hepatology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; CRC 'A. M. And A. Migliavacca' Center for Liver Disease, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy., Aleman S; Department of Infectious Diseases, Karolinska University Hospital/Karolinska Institutet, Stockholm, Sweden., Bourlière M; Hôpital Saint Joseph, Marseille, France., Streinu-Cercel A; National Institute for Infectious Diseases 'Prof. Dr. Matei Bals', Bucharest, Romania.; Carol Davila Medicine and Pharmacy University, Bucharest, Romania., Bogomolov P; M.F. Vladimirsky Moscow Regional Research and Clinical Institute, Moscow, Russian Federation., Morozov V; LLC Medical Company 'Hepatolog', Samara, Russian Federation., Stepanova T; Limited Liability Company 'Clinic of Modern Medicine', Moscow, Russian Federation., Lazar S; Dr. Victor Babes Foundation, Bucharest, Romania., Manuilov D; Gilead Sciences Inc., Foster City, California, USA., Mercier RC; Gilead Sciences Inc., Foster City, California, USA., Tseng S; Gilead Sciences Inc., Foster City, California, USA., Ye L; Gilead Sciences Inc., Foster City, California, USA., Flaherty JF; Gilead Sciences Inc., Foster City, California, USA., Osinusi A; Gilead Sciences Inc., Foster City, California, USA., Da BL; Gilead Sciences Inc., Foster City, California, USA., Chee GM; Gilead Sciences Inc., Foster City, California, USA., Lau AH; Gilead Sciences Inc., Foster City, California, USA., Brunetto MR; Hepatology Unit, Reference Center of the Tuscany Region for Chronic Liver Disease and Cancer, University Hospital of Pisa, Pisa, Italy.; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Wedemeyer H; Clinic for Gastroenterology, Hepatology, Infectious Diseases, and Endocrinology, Hannover Medical School, Hannover, Germany. |
| Source: | Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2025 Apr; Vol. 45 (4), pp. e16174. Date of Electronic Publication: 2024 Dec 08. |
| Publication Type: | Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101160857 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1478-3231 (Electronic) Linking ISSN: 14783223 NLM ISO Abbreviation: Liver Int Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1478-3231 |
|---|---|
| DOI: | 10.1111/liv.16174 |
